Inhaler
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Claims
The ornamental design for an inhaler, as shown and described.
D348929 | July 19, 1994 | Paton |
D370726 | June 11, 1996 | Padfield |
D395147 | June 16, 1998 | Vidgren et al. |
D433502 | November 7, 2000 | Rand |
D439325 | March 20, 2001 | Frost |
D473640 | April 22, 2003 | Cuffaro et al. |
D492994 | July 13, 2004 | King et al. |
D511208 | November 1, 2005 | Pardonge et al. |
D515696 | February 21, 2006 | Lucking et al. |
7325544 | February 5, 2008 | Bruna |
D582543 | December 9, 2008 | Lucking |
D598536 | August 18, 2009 | Parkes |
D620588 | July 27, 2010 | Nielsen |
20050028815 | February 10, 2005 | Deaton et al. |
000688023-0001 | May 2007 | EM |
000688023-0002 | May 2007 | EM |
000688023-0003 | May 2007 | EM |
000688023-0004 | May 2007 | EM |
000688023-0005 | May 2007 | EM |
000688023-0006 | May 2007 | EM |
000688023-0007 | May 2007 | EM |
000688023-0008 | May 2007 | EM |
000688023-0009 | May 2007 | EM |
000688023-0010 | May 2007 | EM |
000688023-0011 | May 2007 | EM |
000688023-0012 | May 2007 | EM |
000688023-0013 | May 2007 | EM |
000688023-0014 | May 2007 | EM |
000688023-0015 | May 2007 | EM |
000688023-0016 | May 2007 | EM |
000688023-0017 | May 2007 | EM |
000688023-0018 | May 2007 | EM |
000688023-0019 | May 2007 | EM |
000688023-0020 | May 2007 | EM |
000688023-0021 | May 2007 | EM |
000688023-0022 | May 2007 | EM |
000688023-0023 | May 2007 | EM |
000688023-0024 | May 2007 | EM |
000688023-0025 | May 2007 | EM |
000688023-0026 | May 2007 | EM |
000688023-0027 | May 2007 | EM |
000688023-0028 | May 2007 | EM |
D1296192 | March 2007 | JP |
D1296193 | March 2007 | JP |
3001971220000 | June 1997 | KR |
3003630260001 | September 2004 | KR |
433889 | February 1989 | TW |
495327 | July 2002 | TW |
495328 | July 2002 | TW |
500591 | August 2002 | TW |
D111283 | June 2006 | TW |
D122108 | September 2006 | TW |
2006097745 | September 2006 | WO |
2007028992 | March 2007 | WO |
2008023019 | February 2008 | WO |
- U.S. Appl. No. 29/322,977, filed Aug. 15, 2008.
- U.S. Appl. No. 12/377,412, filed Feb. 13, 2009.
Type: Grant
Filed: May 10, 2011
Date of Patent: Jan 31, 2012
Assignee: Glaxo Group Limited (Greenford, Middlesex)
Inventors: Gregor John McLennan Anderson (Ware), Matthew Spencer Collins (Shefford), David Vincent Elliman (Halstead), Richard David Lintern (Huntingdon), Andrew Michael Kelly (Ware), Allen John Pearson (Huntingdon), Paul Kenneth Rand (Ware), Mark Digby Teucher (Bristol), James Anthony West (Bristol)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: James P. Riek
Application Number: 29/391,515